US Stock Market Move | Moderna (MRNA.US) rose over 9% after news of negotiations for acquisition with at least one major pharmaceutical company.
As of the time of writing, the stock has risen by more than 9%, reaching $26.95 per share.
On Thursday, Moderna's stock price (MRNA.US) rose, up more than 9% to $26.95 as of press time. In terms of news, a person familiar with the matter revealed that the company is in acquisition negotiations with at least one major pharmaceutical company for a large-scale deal.
Related Articles
US Stock Market Move | Navan (NAVN.US) is listed on the US stock market, and its opening stock price has fallen.
US Stock Market Move | Q3 net loss expands, Roblox (RBLX.US) falls more than 10%
GREENTECH INTL(00195): The 3rd quarter tin production of the Renneson project was 2272 tons, a decrease of 16.6% compared to the previous quarter.
US Stock Market Move | Navan (NAVN.US) is listed on the US stock market, and its opening stock price has fallen.
US Stock Market Move | Q3 net loss expands, Roblox (RBLX.US) falls more than 10%
GREENTECH INTL(00195): The 3rd quarter tin production of the Renneson project was 2272 tons, a decrease of 16.6% compared to the previous quarter.
RECOMMEND
First in History: NVIDIA’s Market Capitalization Tops $5 Trillion
30/10/2025
Congressional Budget Office Estimates Government Shutdown Has Cost the U.S. Economy $18 Billion
30/10/2025
Wall Street on China’s Internet Sector: Distinct Investment Opportunities in AI and Gaming; Caution on E‑commerce
30/10/2025
